| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/27/2005 | EP0831888B1 Methods for increasing hematopoietic cells |
| 07/27/2005 | CN1647268A Carrier, method of manufacturing a carrier and an electronic device |
| 07/27/2005 | CN1646693A Enveloped microorganism |
| 07/27/2005 | CN1646563A Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/27/2005 | CN1646164A Process for the preparation of a nutrient formulation |
| 07/27/2005 | CN1646157A Multiple and multivalent DNA vaccines in ovo |
| 07/27/2005 | CN1646152A Mannose binding lectin and uses thereof |
| 07/27/2005 | CN1646150A Novel use of the extract of processed ginseng and saponin isolated therefrom |
| 07/27/2005 | CN1646096A Apparatus and method for delivery of bacteria to the vaginal tract |
| 07/27/2005 | CN1646093A Method and composition for treatment of inflammation and AIDS-associated neurological disorders |
| 07/27/2005 | CN1646080A Compositions and methods for inducing new hair follicle formation and hair growth in a desired orientation |
| 07/27/2005 | CN1646026A Cheese capable of disinfecting helicobacter pylori |
| 07/27/2005 | CN1646020A Methods and composition for delivering nucleic acids and/or proteins to the respiratory system |
| 07/27/2005 | CN1644106A Steamed stuffed bun |
| 07/27/2005 | CN1644105A Dry flavour Chinese dumplings |
| 07/27/2005 | CN1644096A Production for embryonic powder |
| 07/27/2005 | CN1644094A Biological active preparation of Yak meat and preparing method thereof |
| 07/27/2005 | CN1212155C CD 40 binding molecules and CTL peptides for treating tumors |
| 07/27/2005 | CN1212150C Medicine for treating virus hepatitis and its preparing process |
| 07/27/2005 | CN1212148C External plaster for treating rheumatic arthritis |
| 07/27/2005 | CN1212139C Preparation for treating chronic exhaustion syndrome and its preparing process |
| 07/27/2005 | CN1212138C Anti-senility medicine and its preparation |
| 07/27/2005 | CN1212133C Beautifying health composition and its preparation |
| 07/27/2005 | CN1212130C Medicine for treating psoriasis, ichthyosis and eczema |
| 07/27/2005 | CN1212129C Pills for inducing insulin synthesis and their preparation |
| 07/27/2005 | CN1212127C Medicated sanitary article for treating gynopathy and its preparation |
| 07/26/2005 | US6921665 Generation of differentiaed cells; obtain stem cells, transform with vector coding preferential proteins and reporter molecules, deplete undifferentiated stem cells from culture pool, recover differentiated cells |
| 07/26/2005 | US6921663 Adenovirus vector |
| 07/26/2005 | US6921547 Externally applied medicine for baby's hernia |
| 07/26/2005 | US6921543 Administering immunogenically effective amount of immunogen and an immunomodulatory effective amount of a lipid extract of Perna canaliculus or Mytilus edulis for modulating the immune response to an immunogen in a human or animal patient |
| 07/26/2005 | US6921540 Hypotonic brines comprising mixtures of sodium, potassium, magnesium, calcium, chlorine and sulfates in water, used for prevention of inflammation of mucous membranes and for dissolving plugs in ears |
| 07/26/2005 | CA2005567C Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system |
| 07/21/2005 | WO2005066330A1 A system for improving acceptance of tissue grafts made from embryonic stem cells |
| 07/21/2005 | WO2005065704A1 Preventive and remedy for bone disease |
| 07/21/2005 | WO2005065700A1 Life-prolonging agent comprising polished rice-origin components as the active ingredient |
| 07/21/2005 | WO2005065697A1 Method for the photostabilisation of phycobiliproteins in an aqueous extract, compositions containing stabilised phycobiliproteins and use of stabilised phycobiliproteins |
| 07/21/2005 | WO2005065696A1 Pharmaceutical compositions comprising an extract of euphorbia prostrata |
| 07/21/2005 | WO2005065693A2 Use of cathepsin z inhibitors for the treatment of rheumatoid arthritis and other autoimmune diseases |
| 07/21/2005 | WO2005065396A2 Improved bone matrix compositions and methods |
| 07/21/2005 | WO2005065354A2 Defined media for pluripotent stem cell culture |
| 07/21/2005 | WO2005065269A2 Compositions and method for decreasing the appearance of skin wrinkles |
| 07/21/2005 | WO2005065242A2 Method of treating cancer using platelet releasate |
| 07/21/2005 | WO2005056027A3 Solvent for biogenic active pharmaceutical ingredients |
| 07/21/2005 | WO2005049786A3 Modulation of angiogenesis by bartonella henselae |
| 07/21/2005 | WO2005047473A3 Single vector dual gene therapy for pulmonary hypertension |
| 07/21/2005 | WO2005032567A3 Method to treat the side effects associated with non steroidal anti-inflammatory drugs using microorganisms of the genus bifidobacterium |
| 07/21/2005 | WO2005030251A8 Compositions and methods to accelerate hematologic recovery |
| 07/21/2005 | US20050159822 Particulate acellular tissue matrix |
| 07/21/2005 | US20050159390 Treatment and prevention of HIV and other viral infections |
| 07/21/2005 | US20050159337 Use of botulinum toxin therapy for treatment of overactive bladder |
| 07/21/2005 | US20050159336 Administering activated lymphocytes; promote nerve regeneration |
| 07/21/2005 | US20050158859 Manipulation of non-terminally differentiated cells using the Notch pathway |
| 07/21/2005 | US20050158855 Use of TGF beta superfamily antagonists to make dopaminergic neurons from embryonic stem cells |
| 07/21/2005 | US20050158784 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof |
| 07/21/2005 | US20050158398 Contains lecithin, ginkgo biloba and wheat germ oil; carbon dioxide supercritical extraction to remove cholesterol, glyceride and fatty acids from egg yolk; distillation under low temperature vacuum; nutraceuticals |
| 07/21/2005 | US20050158397 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
| 07/21/2005 | US20050158342 Multi plasmid system for the production of influenza virus |
| 07/21/2005 | US20050158333 Methods and products related to metabolic interactions in disease |
| 07/21/2005 | US20050158317 Novel proteins with il-6 inhibiting activity |
| 07/21/2005 | US20050158292 Lactococcus induces production of IL-10 from mammalian dendritic or spleen cells; treatment of immune diseases including allergy, autoimmune diseases and inflammatory bowel diseases (e.g., large-intestinal ulcer) |
| 07/21/2005 | US20050158291 Pet food composition for skin photoprotection |
| 07/21/2005 | US20050158290 Process for the preparation of a nutrient formulation |
| 07/21/2005 | US20050158289 Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals |
| 07/21/2005 | US20050158288 Methods of organ regeneration |
| 07/21/2005 | US20050158284 Method for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections with bovine red blood cells |
| 07/21/2005 | US20050158282 epidermal growth factor (EGF) producing Lactococcus lactis and Lactobacillus casei ( lactic acid bacterium); useful to treat Short Bowel Syndrome; increase intestinal villi height |
| 07/21/2005 | US20050158278 Means and methods for the production of adenovirus vectors |
| 07/21/2005 | US20050158254 Lactobaccillus; reducing Streptococcus concentration; adjust mucin activity in mouth; anticaries agents; oral disease |
| 07/21/2005 | US20050158244 Cell population from staining a neoplastic cell population with a first marker, staining a dendritic cell population with a second marker, fusing the cells to obtain hybrid cell population stained with both markers; purifying |
| 07/21/2005 | DE10024383B4 Mit toxischen Substanzen beladene dendritische Zellen With toxic substances loaded dendritic cells |
| 07/21/2005 | CA2552411A1 Pharmaceutical compositions comprising an extract of euphorbia prostrata |
| 07/21/2005 | CA2551886A1 Use of cathepsin z inhibitors for the treatment of rheumatoid arthritis and other autoimmune diseases |
| 07/21/2005 | CA2535169A1 Improved bone matrix compositions and methods |
| 07/20/2005 | EP1555319A2 Modified nucleic acid sequences and method to increasing mRNA levels and protein expression in cell systems |
| 07/20/2005 | EP1555031A1 Angiogenesis inducer |
| 07/20/2005 | EP1555028A1 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 07/20/2005 | EP1555027A1 Plasma preparation or serum preparation and process for producing the same |
| 07/20/2005 | EP1555026A2 Chemical modification of mammalian blood |
| 07/20/2005 | EP1554375A2 Adenovirus expressing genes in reverse order and use thereof |
| 07/20/2005 | EP1554374A1 Procedure for the large-scale t-lymphocytes culture in a homogeneous system |
| 07/20/2005 | EP1553969A1 Use of ghrelin for treating malnutrition in gastrectomised individuals |
| 07/20/2005 | EP1553961A1 Use of enteric glia to promote functional nerve connections |
| 07/20/2005 | EP1553960A1 Neuregulin based methods and compositions for treating cardiovascular diseases |
| 07/20/2005 | EP1553959A1 Method for extracting a natural mixture of conjugated equine estrogens that is depleted of non-conjugated lipophilic compounds |
| 07/20/2005 | EP1553936A2 Treatment and rehydration composition which is used to limit the side effects of gastro-enteritis in adults |
| 07/20/2005 | EP1553912A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/20/2005 | EP1553893A2 Implantation of encapsulated biological materials for treating diseases |
| 07/20/2005 | EP1553833A2 Cardiac muscle regeneration using mesenchymal stem cells |
| 07/20/2005 | EP1221982B1 Isoalloxazine derivatives to neutralize biological contaminants |
| 07/20/2005 | EP1198570B1 Monomeric protein of the tgf-beta family |
| 07/20/2005 | EP1121137B1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 07/20/2005 | EP1005538B1 Potassium channel proteins for use in gene therapy for alleviating erectile dysfunction |
| 07/20/2005 | EP0910571B1 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 07/20/2005 | EP0861085B1 Anti-viral isolates obtained from leeches |
| 07/20/2005 | EP0721500B1 Insulin-secreting cell lines, methods of production and use |
| 07/20/2005 | CN1643164A Recombinant bovine immunodeficiency virus based gene transfer system |
| 07/20/2005 | CN1643149A Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 07/20/2005 | CN1643139A Bacteriophages |
| 07/20/2005 | CN1643137A Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 07/20/2005 | CN1643135A Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |